ScholarGate
Asistent

Porovnat metody

Prohlédněte si vybrané metody vedle sebe; řádky, které se liší, jsou zvýrazněny.

Multicentrická klinická studie fáze III×Randomizovaná klinická studie (RCT)×
OborEpidemiologieEpidemiologie
RodinaProcess / pipelineProcess / pipeline
Rok vzniku1940s–1990s (formalized through ICH harmonization ~1990s)1948 (first rigorously conducted RCT — MRC streptomycin trial)
TvůrceCodified through ICH E9 guideline (1998) and decades of regulatory practice (FDA, EMA)Austin Bradford Hill; MRC Streptomycin Trial team
TypConfirmatory interventional study designInterventional experimental study
Původní zdrojFriedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. ISBN: 978-3319185385
Další názvyPhase III multicenter RCT, confirmatory multicenter trial, Phase 3 multicenter study, pivotal multicenter trialRCT, randomized controlled trial, randomised controlled trial, clinical randomized trial
Příbuzné66
ShrnutíA multicenter Phase III clinical trial is the definitive confirmatory study that tests whether a new intervention produces a clinically meaningful benefit over a comparator in a large, representative patient population enrolled at two or more independent research sites. It is the primary evidence basis for regulatory approval by agencies such as the FDA and EMA, combining the statistical power of large samples with the external validity gained from geographic and demographic diversity across sites.A randomized clinical trial (RCT) is an experimental study design in which participants are randomly assigned to an intervention group or a control group, then followed prospectively to compare outcomes. Random allocation is the defining feature: it distributes known and unknown confounders across groups by chance, making the RCT the strongest individual study design for establishing causal efficacy of a treatment or intervention under controlled conditions.
ScholarGateDatová sada
  1. v1
  2. 2 Zdroje
  3. PUBLISHED
  1. v1
  2. 2 Zdroje
  3. PUBLISHED

Přejít na hledání Stáhnout prezentaci

ScholarGatePorovnat metody: Multicenter Phase III Clinical Trial · Randomized clinical trial. Získáno 2026-06-19 z https://scholargate.app/cs/compare